Abstract:Introduction Malignant priapism is a rare condition characterized by persistent erection resulting from the invasion or metastasis of a primary neoplasm. Penile metastases arise from the genitourinary tract 64% of the time (bladder: 28.6%, prostate: 27.9%, kidney: 6.9%, ureter: 0.5%) with colorectal adenocarcinoma, lung cancer, melanoma, and hematologic diseases comprising the remainder. Malignant priapism is reported to occur in 20-53% of patients with penile metastasis. The mechanism of malignant priapism remains unknown. The most accepted theory is an invasion of the corpus cavernosum as well as associated venous systems with malignant cells. This can occur from either hematogenous or lymphatic spread from the source tumor. Resulting derangement of arterial or veno-occlusive mechanism causes priapism. Both ischemic and non-ischemic priapism can occur. Objective While treatment guidelines for priapism in non-malignant cases have been established, there is currently no guideline for treating malignant priapism. This study aims to present three cases of malignant priapism resulting from advanced genitourinary cancers and evaluate the efficacy of palliative penectomy as a treatment modality for relieving symptoms associated with malignant priapism. Methods We conducted a retrospective analysis of three cases of malignant priapism associated with advanced genitourinary cancers. Data were collected from medical records, including patient demographics, primary tumor characteristics, clinical presentation, treatment modalities, complications, and outcomes. The main treatment approach utilized in all cases was palliative penectomy. Symptom relief and complications were assessed as primary outcomes. Results All three patients presented with progressive penile pain, and imaging studies confirmed the presence of metastatic disease involving the penile structures. Palliative penectomy was performed in all cases, resulting in sustained relief of symptoms. No major complications were reported during the surgical procedures. Follow-up assessments showed improved quality of life in terms of pain relief, but all patients died within a short period following penectomy owing to the advanced predisposing malignancy. (figure 1) Conclusions Treatment of malignant priapism needs to be individualized to the needs of the patient. No matter the primary or secondary nature of the disease, current data suggest that malignant priapism is associated with poor outcomes, and emphasis should be put on palliative care. Although new radiation techniques have shown favorable outcomes, penectomy should be considered the last resort in clinical management. Revisions to the existing management guidelines for priapism are necessary to address its occurrence in malignant contexts. (figure 2) Disclosure No.

Artificial Intelligence Modeling and Priapism

Adenosine Signaling in Priapism and Novel Therapies

Excess Adenosine A2B Receptor Signaling Contributes to Priapism Through HIF-1α Mediated Reduction of PDE5 Gene Expression.

The Promise of Artificial Intelligence in Peyronie's Disease

[Considerations on Priapism].

Idiopathic recurrent ischemic priapism: a review of current literature and an algorithmic approach to evaluation and management

European Association of Urology guidelines on priapism

Contemporary management of ischemic priapism: A 12-year population-based analysis from a large US database

The Risk of Cardiovascular and Cerebrovascular Disease in Men with a History of Priapism

Review of the role of imaging in the diagnosis of priapism

Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections: a cross-sectional analysis

Loxapine-Induced Priapism: A Case Report and Review of the Literature on Antipsychotic-Induced Priapism

Recurrent ischemic priapism(a case report and literature review)

(324) History of Priapism Treatment in the 20th Century

Diagnosis and Treatment of Priapism (report of 10 Cases)

What Is Priapism?

Decision support in supervisory control of high-risk industrial systems

(019) Malignant Priapism: Case Report and Update on Management Protocols

Study of the Etiology and Risk Factors in Patients with Ischemic Priapism

[Anti-thrombotic effect of nitric oxide].